Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-10 Sale |
2020-06-12 5:19 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
73,725 | $66.09 | $4,872,602 | 24,294 (Direct) |
View |
| 2020-06-08 Sale |
2020-06-10 9:24 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
600 | $70.05 | $42,027 | 28,039 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-10 Exercise |
2020-06-12 5:19 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
31,225 | $9.29 | 24,294 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:19 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
17,500 | $0.61 | 24,294 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:19 pm |
N/A 2026-12-14 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
73,725 | $0 | 24,294 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:19 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
25,000 | $5.6 | 24,294 (Direct) |
View |
| 2020-06-08 Exercise |
2020-06-10 9:24 pm |
N/A 2025-10-22 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
600 | $0 | 28,039 (Direct) |
View |
| 2020-06-08 Exercise |
2020-06-10 9:24 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
600 | $5.6 | 28,039 (Direct) |
View |
| 2020-06-05 Exercise |
2020-06-08 5:15 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
37,700 | $9.29 | 2,995,658 (Direct) |
View |
| 2020-06-05 Exercise |
2020-06-08 5:15 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
212,500 | $0.61 | 2,995,658 (Direct) |
View |
| 2020-06-05 Exercise |
2020-06-08 5:15 pm |
N/A 2028-04-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
438,200 | $0 | 2,995,658 (Direct) |
View |
| 2020-06-05 Exercise |
2020-06-08 5:15 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
20,000 | $10.82 | 2,995,658 (Direct) |
View |
| 2020-06-05 Tax Withholding |
2020-06-08 5:15 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
30,143 | $68.15 | 2,995,658 (Direct) |
View |
| 2020-06-05 Exercise |
2020-06-08 5:15 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
150,000 | $5.6 | 2,995,658 (Direct) |
View |
| 2020-06-05 Exercise |
2020-06-08 5:15 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
18,000 | $28.76 | 2,995,658 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 9:14 pm |
N/A 2030-04-29 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 9:14 pm |
N/A 2030-04-29 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 9:14 pm |
N/A 2030-04-29 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 9:14 pm |
N/A 2030-04-29 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 9:14 pm |
N/A 2030-04-29 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Heffernan Michael Thomas Director |
18,000 | $0 | 18,000 (Direct) |
View |